Citations

Mayo Clinic

Showing 10 of 108602 citations.

Prospective Assessment of the Prevalence of Enter Hyperoxalosis in Kidney Transplant Candidates
Mejia, Christina , Tariq, Anam , Alotaibi, Manal, Lakhani, Laila, Greenspan, Wendy , Naqvi, Fizza , Alasfar, Sami , Brennan, Daniel C. , Lakhani, Laila Saleem

Transplantation Direct | March 30, 2023 | Volume: 9 | Issue: 4 | Pages: e1464

10.1097/txd.0000000000001464 | PMID 37009166 Get It

Background. Enteric hyperoxalosis (EH) is an emerging cause of kidney transplantation (KT) dysfunction. We sought to determine the prevalence of EH and factors that affect plasma oxalate (POx) among at-risk KT candidates. Methods. We prospectively measured POx among KT candidates evaluated at our center from 2017 to 2020 with risk factors for EH namely bariatric surgery, inflammatory bowel disease, or cystic fibrosis. EH was defined by a POx ≥10 μmol/L. Period-prevalence of EH was calculated. We compared mean POx across 5 factors: underlying condition, chronic kidney disease (CKD) stage, dialysis modality, phosphate binder type, and body mass index. Results. Of 40 KT candidates screened, 23 had EH for a 4-y period prevalence of 58%. Mean POx was 21.6 ± 23.5 μmol/L ranging from 0 to 109.6 μmol/L. 40% of screened had POx >20 μmol/L. Sleeve gastrectomy was the most common underlying condition associated with EH. Mean POx did not differ by underlying condition (P = 0.27), CKD stage (P = 0.17), dialysis modality (P = 0.68), phosphate binder (P = 0.58), and body mass index (P = 0.56). Conclusions. Bariatric surgery and inflammatory bowel disease were associated with a high prevalence of EH among KT candidates. Contrary to prior studies, sleeve gastrectomy was also associated with hyperoxalosis in advanced CKD. POx concentrations observed in EH reached levels associated with tissue and potentially allograft deposition. Concentrations can be as high as that seen in primary hyperoxaluria. More studies are needed to assess if POx is indeed a modifiable factor affecting allograft function in patients with EH.
Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial)
Morris, Michael J. , Hillman, David W. , Bobek, Olivia , Ryan, Charles J. , Antonarakis, Emmanuel S. , Bryce, Alan H. , Hahn, Olwen, Beltran, Himisha , Armstrong, Andrew J. , Schwartz, Lawrence B. , Langevin, Brooke , McGary, Eric C., Mehan, Paul, Goldkorn, Amir , Roth, Bruce J. , Xiao, Han , Watt, Colleen, Taplin, Mary‐Ellen , Halabi, Susan , Antonarakis, Emmanuel S. , Hillman, David W , Bobek, Olivia , Antonarakis, Emmanuel S , Bryce, Alan H , Beltran, Himisha , Armstrong, Andrew J , Beumer, Jan Hendrik , Goldkorn, Amir , Roth, Bruce J , Xiao, Han , Halabi, Susan , Small, Eric J , Morris, Michael J , Antonarakis, Emmanuel S , Heller, Glenn , Lewis, Lionel D. , Small, Eric J.

Journal of Clinical Oncology | March 30, 2023 | Volume: 41 | Issue: 18 | Pages: 3352-3362

10.1200/jco.22.02394 | PMID 36996380 Get It

PURPOSE Enzalutamide and abiraterone both target androgen receptor signaling but via different mechanisms. The mechanism of action of one drug may counteract the resistance pathways of the other. We sought to determine whether the addition of abiraterone acetate and prednisone (AAP) to enzalutamide prolongs overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC) in the first-line setting. PATIENTS AND METHODS Men with untreated mCRPC were randomly assigned (1:1) to receive first-line enzalutamide with or without AAP. The primary end point was OS. Toxicity, prostate-specific antigen declines, pharmacokinetics, and radiographic progression-free survival (rPFS) were also examined. Data were analyzed using an intent-to-treat approach. The Kaplan-Meier estimate and the stratified log-rank statistic were used to compare OS between treatments. RESULTS In total, 1,311 patients were randomly assigned: 657 to enzalutamide and 654 to enzalutamide plus AAP. OS was not statistically different between the two arms (median, 32.7 [95% CI, 30.5 to 35.4] months for enzalutamide v 34.2 [95% CI, 31.4 to 37.3] months for enzalutamide and AAP; hazard ratio [HR], 0.89; one-sided P = .03; boundary nominal significance level = .02). rPFS was longer in the combination arm (median rPFS, 21.3 [95% CI, 19.4 to 22.9] months for enzalutamide v 24.3 [95% CI, 22.3 to 26.7] months for enzalutamide and AAP; HR, 0.86; two-sided P = .02). However, pharmacokinetic clearance of abiraterone was 2.2- to 2.9-fold higher when administered with enzalutamide, compared with clearance values for abiraterone alone. CONCLUSION The addition of AAP to enzalutamide for first-line treatment of mCRPC was not associated with a statistically significant benefit in OS. Drug-drug interactions between the two agents resulting in increased abiraterone clearance may partly account for this result, although these interactions did not prevent the combination regimen from having more nonhematologic toxicity.
Ventricular arrhythmias in patients with prior aortic valve intervention: Characteristics, ablation and outcomes
Khalil, Fouad , Ahmad, Ali , Siontis, Konstantinos C. , Mulpuru, Siva K. , Munoz, Freddy Del‐Carpio , Cha, Yong‐Mei , Friedman, Paul A. , Munger, Thomas M. , Asirvatham, Samuel J. , Killu, Ammar M. , Siontis, Konstantinos C , Mulpuru, Siva K , Del-Carpio Munoz, Freddy , Cha, Yong-Mei , Friedman, Paul A , Munger, Thomas, Asirvatham, Samuel J , Killu, Ammar M , Khalil, Fouad , Toya, Takumi

Journal of Cardiovascular Electrophysiology | March 30, 2023 | Volume: 34 | Issue: 5 | Pages: 1206-1215

10.1111/jce.15896 | PMID 36994918 Get It

AbstractIntroductionData regarding ventricular tachycardia (VT) or premature ventricular complex (PVC) ablation in patients with aortic valve (AV) intervention (AVI) is limited. Catheter ablation (CA) can be challenging given perivalvular substrate in the setting of prosthetic valves. We sought to investigate the characteristics, safety, and outcomes of CA in patients with prior AVI and ventricular arrhythmias (VA).MethodsWe identified consecutive patients with prior AVI (replacement or repair) who underwent CA for VT or PVC between 2013 and 2018. We investigated the mechanism of arrhythmia, ablation approach, perioperative complications, and outcomes.ResultsWe included 34 patients (88% men, mean age 64 ± 10.4 years, left ventricular (LV) ejection fraction 35.2 ± 15.0%) with prior AVI who underwent CA (22 VT; 12 PVC). LV access was obtained through trans‐septal approach in all patients except one patient who had percutaneous transapical access. One patient had combined retrograde aortic and trans‐septal approach. Scar‐related reentry was the dominant mechanism of induced VTs. Two patients had bundle branch reentry VTs. In the VT group, substrate mapping demonstrated heterogeneous scar that involved the peri‐AV area in 95%. Despite that, the site of successful ablation included the periaortic region only in 6 (27%) patients. In the PVC group, signal abnormalities consistent with scar in the periaortic area were noted in 4 (33%) patients. In 8 (67%) patients, the successful site of ablation was unrelated to the periaortic area. No procedure‐related complications occurred. The survival and recurrence‐free survival rate at 1 year tended to be lower in VT group than in PVC group (p = .06 and p = .05, respectively) with a 1‐year recurrence‐free survival rate of 52.8% and 91.7%, respectively. No arrhythmia‐related death was documented on long‐term follow‐up.ConclusionCA of VAs can be performed safely and effectively in patients with prior AVI.
Clinical characteristics and outcomes of cervical cancer in Asian Indian and Pakistani Americans (AIPA)
Gaire, Suman , Karki, Ujjwal , Budhathoki, Pravash , Shah, Anish , Yadav, Siddhartha

International Journal of Cancer Care and Delivery | March 30, 2023 | Volume: 3 | Issue: Supplement 1 | Pages: No page available

10.53876/001c.73918 Get It

Disease characteristics and clinical outcomes of endometrial cancer in Asian Indian and Pakistani American (AIPA) women
Gaire, Suman , Shah, Anish , Budhathoki, Pravash , Karki, Ujjwal , Yadav, Siddhartha

International Journal of Cancer Care and Delivery | March 30, 2023 | Volume: 3 | Issue: Supplement 1 | Pages: No page available

10.53876/001c.73764 Get It

RadioGraphics Update: Pictorial Guide to CAD-RADS 2.0
Canan, Arzu , Kay, Fernando Uliana , Barbosa, Maurício Fregonesi , Abbara, Suhny , Rajiah, Prabhakar , Kay, Fernando , Rajiah, Prabhakar

RadioGraphics | March 30, 2023 | Volume: 43 | Issue: 4 | Pages: No page available

10.1148/rg.220202 | PMID 36995944 Get It

Recovery from COVID-19 in Adult Recreational Athletes: A Survey of American Triathletes
Getzin, Andrew, Creswell, Lawrence L., Asplund, Chad A., Schroeder, Allison N.

Exercise, Sport and Movement | March 30, 2023 | Volume: 1 | Issue: 2 | Pages: No page available

10.1249/esm.0000000000000005 Get It

ABSTRACT Introduction/Purpose Little is currently known regarding coronavirus disease 2019 (COVID-19) symptomatology and return to exercise, training, and fitness after COVID-19 in adult recreational athletes. The purpose of this study was to determine which COVID-19-related symptoms are associated with prolonged return to sport in U.S. triathletes. Methods This was an online survey cohort study of USA Triathlon members (104 participants). Self-reported participant demographics, comorbid conditions, symptoms, and complications experienced with COVID-19 were assessed. Time required for the athlete to return to exercise, training, and normal fitness and whether symptoms worsened upon return to training were determined. Results Survey respondents were predominantly male (average age, 44.5 ± 1.9 yr) and healthy at baseline (91.0% had no risk factors for COVID-19 and 76.9% had no potential risk factors). After COVID-19, 50% of athletes returned to exercise in <1 wk, 30% returned to training in <1 wk, and 39% returned to normal fitness in <1 month. Thirty-five athletes (33.7%) felt worse upon return to training. Return to training took >14 d in more than 50% of athletes, and only 13% took >8 wk to return to normal fitness. Fever, shortness of breath, fatigue, and headache were all associated with prolonged return to exercise, training, and fitness (all P < 0.05). Conclusions Triathletes with COVID-19 who experienced fever, shortness of breath, headache, and fatigue should be counseled that they may have a more prolonged return to exercise, training, and normal fitness compared with those with less severe symptoms.
Understanding Variation in In-hospital Mortality After Major Surgery in the United States
Chang, Yu‐Hui, Etzioni, David A. , Stucky, Chee‐Chee , Wasif, Nabil , Etzioni, David, Martins, Russell Seth , Cronin, Patricia

Annals of Surgery | March 30, 2023 | Volume: 278 | Issue: 6 | Pages: 865-872

10.1097/sla.0000000000005862 | PMID 36994756 Get It

Objectives: We aimed to quantify the contributions of patient characteristics (PC), hospital structural characteristics (HC), and hospital operative volumes (HOV) to in-hospital mortality (IHM) after major surgery in the United States (US). Background: The volume-outcome relationship correlates higher HOV with decreased IHM. However, IHM after major surgery is multifactorial, and the relative contribution of PC, HC, and HOV to IHM after major surgery is unknown. Study Design: Patients undergoing major pancreatic, esophageal, lung, bladder, and rectal operations between 2006 and 2011 were identified from the Nationwide Inpatient Sample linked to the American Hospital Association survey. Multilevel logistic regression models were constructed using PC, HC, and HOV to calculate attributable variability in IHM for each. Results: Eighty thousand nine hundred sixty-nine patients across 1025 hospitals were included. Postoperative IHM ranged from 0.9% for rectal to 3.9% for esophageal surgery. Patient characteristics contributed most of the variability in IHM for esophageal (63%), pancreatic (62.9%), rectal (41.2%), and lung (44.4%) operations. HOV explained < 25% of variability for pancreatic, esophageal, lung, and rectal surgery. HC accounted for 16.9% and 17.4% of the variability in IHM for esophageal and rectal surgery. Unexplained variability in IHM was high in the lung (44.3%), bladder (39.3%), and rectal (33.7%) surgery subgroups. Conclusions: Despite recent policy focus on the volume-outcome relationship, HOV was not the most important contributor to IHM for the major organ surgeries studied. PC remains the largest identifiable contributor to hospital mortality. Quality improvement initiatives should emphasize patient optimization and structural improvements, in addition to investigating the yet unexplained sources contributing to IHM.
Technical Pitfalls for Fenestrated-Branched Endovascular Aortic Repair Following PETTICOAT
Baghbani‐Oskouei, Aidin , Tenorio, Emanuel R. , Dias‐Neto, Marina , Vacirca, Andrea , Mirza, Aleem K. , Saqib, Naveed, Mendes, Bernardo C. , Ocasio, Laura , Macedo, Thanila A. , Oderich, Gustavo S. , Baghbani, Aidin , Tenorio, Emanuel R , Oderich, Gustavo S , Dias-Neto, Marina

Journal of Endovascular Therapy | March 30, 2023 | Volume: 31 | Issue: 5 | Pages: 790-796

10.1177/15266028231163439 | PMID 36995081 Get It

Purpose: The Provisional Extension to Induce Complete Attachment Technique (PETTICOAT) uses a bare-metal stent to scaffold the true lumen in patients with acute or subacute aortic dissections. While it is designed to facilitate remodeling, some patients with chronic post-dissection thoracoabdominal aortic aneurysms (TAAAs) require repair. This study describes the technical pitfalls of fenestrated-branched endovascular aortic repair (FB-EVAR) in patients who underwent prior PETTICOAT repair. Technique: We report 3 patients with extent II TAAAs who had prior bare-metal dissection stents treated by FB-EVAR. Two patients required maneuvers to reroute the aortic guidewire, which was initially placed in-between stent struts. This was recognized before the deployment of the fenestrated-branched device. A third patient had difficult advancement of the celiac bridging stent due to a conflict of the tip of the stent delivery system into one of the stent struts, requiring to redo catheterization and pre-stenting with a balloon-expandable stent. There were no mortalities and target-related events after a follow-up of 12 to 27 months. Conclusion: FB-EVAR following the PETTICOAT is infrequent, but technical difficulties should be recognized to prevent complications from the inadvertent deployment of the fenestrated-branched stent-graft component in-between stent struts. Clinical Impact The present study highlights a few maneuvers to prevent or overcome possible complications during endovascular repair of chronic post-dissection thoracoabdominal aortic aneurysm following PETTICOAT. The main problem to be recognized is the placement of the aortic wire beyond one of the struts of the existing bare-metal stent. Moreover, encroachment of catheters or the bridging stent delivery system into the stent struts may potentially cause difficulties.
The Role of Shear Stress in Coronary Artery Disease
Siasos, Gerasimos , Tsigkou, Vasiliki , Coskun, Ahmet U. , Zaromitidou, Marina , Lerman, Lilach O. , Stone, Peter H. , Oikonomou, Evangelos , Lerman, Amir

Current Topics in Medicinal Chemistry | March 30, 2023 | Volume: 23 | Issue: 22 | Pages: 2132-2157

10.2174/1568026623666230329085631 | PMID 36999430 Get It

Abstract:Coronary artery disease is the leading cause of morbidity and mortality worldwide, espe-cially in developed countries, with an increasing incidence in developing countries. Despite the ad-vances in cardiology, there are yet many unanswered questions about the natural history of coronary atherosclerosis. However, it has not been fully explained why some coronary artery plaques remain quiescent over time, whereas others evolve to a high-risk, “vulnerable” plaque with a predisposition to destabilize and induce a cardiac event. Furthermore, approximately half of the patients with acute coronary syndromes demonstrate no prior symptoms of ischemia or angiographically evident dis-ease. Recent findings have indicated that apart from cardiovascular risk factors, genetics, and other unknown factors, local hemodynamic forces, such as endothelial shear stress, blood flow patterns, and endothelial dysfunction of the epicardial and microvascular coronary arteries, are associated with the progression of coronary plaque and the development of cardiovascular complications with complex interactions. In this review article, we summarize the mechanisms that affect coronary ar-tery plaque progression, indicating the importance of endothelial shear stress, endothelial dysfunc-tion of epicardial and microvascular vessels, inflammation, and their complex associations, underly-ing in parallel the clinical perspectives of these findings.